# Zentalis Pharmaceuticals, LLC (ZNTL)

ZNTL stock shows upward trend after positive Phase [--] data for ZN-c3, but regulatory and manufacturing concerns loom. Social media buzz is high, with recent posts highlighting clinical trial updates and market news.

### About Zentalis Pharmaceuticals, LLC
Zentalis Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies.  
Zentalis Pharmaceuticals, LLC uses the ticker $ZNTL for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Zentalis Pharmaceuticals, LLC (ZNTL) social dominance is up 725% from the previous week.
- Zentalis Pharmaceuticals, LLC (ZNTL) Galaxy Score™ is up 41.67% from the previous week.
- Zentalis Pharmaceuticals, LLC (ZNTL) sentiment is up 20.48% from the previous week.

### Price: $2.40
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/close.tsv)  
The stock price has seen a recent upward trend, likely driven by positive Phase [--] data for ZN-c3, indicating investor optimism. However, concerns about regulatory approval timelines and manufacturing scale-up may be limiting more substantial gains.  

24-Hour: 1.43%
7-Day: 3.53%
30-Day: -19.26%

1-Year High: $3.70 on 2026-01-09  
1-Year Low: $1.20 on 2025-06-30  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/alt_rank.tsv)  
Zentalis Pharmaceuticals, LLC (ZNTL) is currently AltRank #1,400 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +1,864  
1-Year High: [-----] on 2026-02-14  
1-Year Low: [---] on 2026-01-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +10  
1-Year High: [--] on 2026-02-03  
1-Year Low: [--] on 2026-02-05  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [-----] -37%  
[--] Month: [------] -77%  
[--] Months: [-------] +44%  
[--] Year: [-------] -60%  
1-Year High: [------] on 2026-01-12  
1-Year Low: [--] on 2025-09-07  

Engagements by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +0.79%  
1-Year High: [---] on 2026-01-11  
1-Year Low: [--] on 2025-12-07  

Mentions by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Zentalis Pharmaceuticals, LLC (ZNTL) in the last [--] hours which is up 5.90% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] -14%  
1-Year High: [---] on 2026-01-10  
1-Year Low: [--] on 2025-12-07  
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 89%  
[--] Week: 100% +17%  
[--] Month: 100% +17%  
[--] Months: 100% no change  
[--] Year: 100% no change  
1-Year High: 100% on 2025-02-15  
1-Year Low: 33% on 2025-05-29  

Most Supportive Themes:
- Zentalis Pharmaceuticals Announces Positive Phase [--] Data for ZN-c3: (70%) Zentalis Pharmaceuticals LLC presented encouraging Phase [--] clinical trial results for their drug candidate ZN-c3, showing significant efficacy in treating certain types of cancer. The data has been met with enthusiasm from the oncology community and investors.
- Zentalis Expands Clinical Trial Pipeline with New Cancer Targets: (30%) The company is broadening its research and development efforts, initiating new clinical trials for ZN-c3 and other promising compounds targeting various advanced cancers. This expansion signals a commitment to addressing unmet medical needs.
  
Most Critical Themes:
- Regulatory Hurdles and Competition in Oncology Drug Development: (60%) Zentalis Pharmaceuticals faces a competitive landscape and stringent regulatory pathways for new cancer therapies. The success of ZN-c3 will depend on navigating these challenges effectively and demonstrating a clear advantage over existing treatments.
- Manufacturing Scale-Up and Supply Chain Considerations for ZN-c3: (40%) Ensuring a robust and scalable manufacturing process for ZN-c3 is crucial for its eventual market availability. Potential supply chain disruptions or manufacturing complexities could impact the drug's timely delivery to patients.
  
  
  
### Social Dominance: 0.00208%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/social_dominance.tsv)  
Current Value: 0.00208%  
Daily Average: 0.00467%  
[--] Week: 0.0033% +0.0029%  
[--] Month: 0.003% -0.011%  
[--] Months: 0.003% +0.0015%  
[--] Year: 0.003% -0.0061%  
1-Year High: 0.061% on 2026-01-11  
1-Year Low: 0.0002% on 2025-10-04  
  
  
### Market Dominance: 0.00017525305003793882%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/market_dominance.tsv)  
Current Value: 0.00017525305003793882%  
Daily Average: 0%  
1-Year High: 0.00726% on 2026-01-13  
1-Year Low: 0.00018% on 2026-02-14  
  
  
### Market Cap: $154,754,362
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:zentalis-pharmaceuticals-llc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/zentalis-pharmaceuticals-llc/time-series/market_cap.tsv)  
Current Value: $154,754,362  
Daily Average: $175,768,933  
[--] Week: $153,679,499 +3.60%  
[--] Month: $154,754,362 -24%  
1-Year High: $227,275,234 on 2026-01-14  
1-Year Low: $143,099,222 on 2026-02-05

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing